238 related articles for article (PubMed ID: 31666702)
1. Immunity to commensal papillomaviruses protects against skin cancer.
Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
[TBL] [Abstract][Full Text] [Related]
2. An Emerging Issue in Oncogenic Virology: the Role of Beta Human Papillomavirus Types in the Development of Cutaneous Squamous Cell Carcinoma.
Rollison DE; Viarisio D; Amorrortu RP; Gheit T; Tommasino M
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700603
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts.
Biliris KA; Koumantakis E; Dokianakis DN; Sourvinos G; Spandidos DA
Cancer Lett; 2000 Dec; 161(1):83-8. PubMed ID: 11078916
[TBL] [Abstract][Full Text] [Related]
4. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous HPV and skin cancer.
Accardi R; Gheit T
Presse Med; 2014 Dec; 43(12 Pt 2):e435-43. PubMed ID: 25451638
[TBL] [Abstract][Full Text] [Related]
6. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
7. Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.
Wang J; Aldabagh B; Yu J; Arron ST
J Am Acad Dermatol; 2014 Apr; 70(4):621-629. PubMed ID: 24629358
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and biology of cutaneous human papillomavirus.
Nunes EM; Talpe-Nunes V; Sichero L
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e489s. PubMed ID: 30133564
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
12. Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.
Vinzón SE; Braspenning-Wesch I; Müller M; Geissler EK; Nindl I; Gröne HJ; Schäfer K; Rösl F
PLoS Pathog; 2014 Feb; 10(2):e1003924. PubMed ID: 24586150
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.
Venuti A; Lohse S; Tommasino M; Smola S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180287. PubMed ID: 30955489
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.
Harwood CA; Surentheran T; McGregor JM; Spink PJ; Leigh IM; Breuer J; Proby CM
J Med Virol; 2000 Jul; 61(3):289-97. PubMed ID: 10861635
[TBL] [Abstract][Full Text] [Related]
16. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
17. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
[TBL] [Abstract][Full Text] [Related]
20. The interplay of UV and cutaneous papillomavirus infection in skin cancer development.
Hasche D; Stephan S; Braspenning-Wesch I; Mikulec J; Niebler M; Gröne HJ; Flechtenmacher C; Akgül B; Rösl F; Vinzón SE
PLoS Pathog; 2017 Nov; 13(11):e1006723. PubMed ID: 29190285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
